Loading...

IART INTEGRA LIFESCIENCES HOLDINGS CORP Earnings Reports 8-K Filing

NTGR

RT

INTEGRA LIFESCIENCES HOLDINGS CORP

(IART)

2025 8-K

Earnings Results

Severance Program Update

Q3 2025 Results

Financial Statements

Debt-Equity Swaps

Financial Statements

Earnings Announcement

FDA Warning Letter

Severance Program

Q3 2024 Results

CEO Appointment

Financial Results Announcement

Share Repurchase Agreement

Annual Meeting and Share Re...

Financial Results Announcement

Retirement and Appointment

Financial Results Announcement

Amendment to Filing

Agreement Amendment

Appointment of Director, Ch...

Acquisition Agreement

Financial Results Announcement

Share Repurchase Agreement

Financial Results and FDA W...

Appointment of CFO

Material Impairments

Annual Meeting of Stockholders

Financial Results

External Links:

Integra LifeSciences Holdings Corp reported its financial results for Q3 2025, announcing adjusted earnings and revenue figures compared to Q3 2024. The results include various reconciliations of GAAP to non-GAAP metrics and emphasize operational adjustments following a recall.

AI Assistant

INTEGRA LIFESCIENCES HOLDINGS CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.